Latest content

  • NanoTemper Technologies announces Dianthus α, an applications package, to push the boundaries of in-solution binding analysis.  

    NanoTemper Technologies announces Dianthus α, an applications package, to push the boundaries of in-solution binding analysis.  

    Drug discovery teams need high-confidence data to accelerate hit-to-lead workflows and take on targets once considered undruggable.

    Read
  • NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market

    NanoTemper Technologies unveils Dianthus uHTS — the fastest biophysical method on the market

    NanoTemper Technologies has established an advisory board consisting of five distinguished professionals, each a seasoned expert in their respective fields. This move underscores NanoTemper...

    Read
  • Proximity Inducers in Drug Discovery - A Perspective on Cooperativity

    Proximity Inducers in Drug Discovery - A Perspective on Cooperativity

    Read
  • Ultra-high-throughput biophysical screening of MEK1 using the Dianthus uHTS platform

    Ultra-high-throughput biophysical screening of MEK1 using the Dianthus uHTS platform

    Read
  • Targeted protein degradation promises to lead the way to effective drugs for challenging targets

    Targeted protein degradation promises to lead the way to effective drugs for challenging targets

    Read
  • 8 Targeted Protein Degradation conferences in 2023 you won’t want to miss

    8 Targeted Protein Degradation conferences in 2023 you won’t want to miss

    2023 is expected to be a year of big announcements in the targeted protein degradation (TPD) therapeutics space. With more than 20 degraders in clinical trials, many decisions are coming. The race...

    Read
  • ×

    Sign up to receive
    the latest NanoTemper news, product updates, event announcements and more

    First Name
    Last Name
    Company Name
    Country
    State
    Province
    State
    Region
    State
    Canton
    Agree to Subscribe & Privacy Policy*
    *I have fully read, understood and agree to the Privacy Policy. I accept the storing and processing of my personal data by NanoTemper as described in the Privacy Policy.

    By completing this form, you provide us consent to contact you with educational content, news and information about our products, services and events. You may unsubscribe at any time.
    Thank you!
    Error - something went wrong!
  • How to keep your degrader pipeline moving forward with Dianthus16:42

    How to keep your degrader pipeline moving forward with Dianthus

    The development of your protein degrader is a multi-step and complex process usually packed with challenges that if left unsolved will delay the progress of your project. What if you could overcome co

    Watch
  • Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift22:23

    Selective degradation of cancer target WDR5 — Evaluation of PROTACs binary and ternary affinities with Spectral Shift

    Chances are your company’s research and development pipeline includes several PROTAC candidates — placing you with many others in the race to bring successful and efficient protein degraders to the cl

    Watch
  • Interactions of liposome embedded SNARE proteins

    Interactions of liposome embedded SNARE proteins

    Read
  • Contact Specialist
  • A protein superfamily meets its match in nanoDSF

    A protein superfamily meets its match in nanoDSF

    G protein-coupled receptors (GPCRs) are the largest class of targets for drug discovery, and the fourth largest superfamily in the human genome. They have been linked to the regulation of many...

    Read
  • Thermophoretic analysis of ligand-specific conformational states of the inhibitory glycine receptor embedded in copolymer nanodiscs

    Thermophoretic analysis of ligand-specific conformational states of the inhibitory glycine receptor embedded in copolymer nanodiscs

    Read
  • Practical Guide: Quality Control Strategies for Membrane Proteins

    Practical Guide: Quality Control Strategies for Membrane Proteins

    When working with membrane proteins, whether you’re troubleshooting aggregation, testing new solubilization strategies, or deciding when to switch detergents read this guide for practical solutions.

    Read
  • Targeted degradation of a hypoxia-associated non-coding RNA enhances the selectivity of a small molecule interacting with RNA

    Targeted degradation of a hypoxia-associated non-coding RNA enhances the selectivity of a small molecule interacting with RNA

    Read
  • Targeting the SARS-CoV‑2 RNA genome with small molecule binders and ribonuclease targeting chimera (RIBOTAC) degraders

    Targeting the SARS-CoV‑2 RNA genome with small molecule binders and ribonuclease targeting chimera (RIBOTAC) degraders

    Read
  • Sweet and blind spots in E3 ligase ligand space revealed by a thermophoresis-based assay

    Sweet and blind spots in E3 ligase ligand space revealed by a thermophoresis-based assay

    Read
  • Ddi1 is a ubiquitin-dependent protease

    Ddi1 is a ubiquitin-dependent protease

    Read
  • For protein degraders to tackle neurodegenerative diseases, these are the barriers they need to overcome

    For protein degraders to tackle neurodegenerative diseases, these are the barriers they need to overcome

    The total protein degradation modality — locally and specifically targeting the disease-causing proteins and degrading their toxic aggregates — promises to be revolutionary. But the development of...

    Read
  • Improve your protein degrader design with new ways to discover E3 ligase ligands35:47

    Improve your protein degrader design with new ways to discover E3 ligase ligands

    Targeted protein degradation using molecular glues or proteolysis-targeting chimeras (PROTACs) is an increasingly important therapeutic modality, especially for undruggable targets. Even with candidat

    Watch
  • Attend these targeted protein degradation conferences in 2024 to stay in the know

    Attend these targeted protein degradation conferences in 2024 to stay in the know

    Attending dedicated targeted protein degradation conferences and tracks is a great way to keep up with this rapidly evolving field. Here are 8 conferences you’ll want to attend in 2024.

    Read
  • 10 Evolved Terms Every Scientist Should Know About Targeted Protein Degradation in 2025

    10 Evolved Terms Every Scientist Should Know About Targeted Protein Degradation in 2025

    Explore 10 advanced concepts redefining targeted protein degradation in 2025, including AI-guided design, novel degrader modalities, and tissue-specific E3 ligases for scientists working on TPD

    Read
  • loading
    Loading more...